Kellie Machlus: CCL5 as a Driver of Megakaryopoiesis and Platelet Recovery
Kellie Machlus, Associate Professor at Harvard Medical School, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood, adding:
“So excited to share with everyone our latest publication – led by Maria Barrachina while she was in the lab (go work with her in Ohio!).
This is an extension of our previous work, which now shows in vivo and BM organoid effects of CCL5 on the MK lineage including HSC and MKP expansion and increased platelet production after thrombocytopenia.
Check it out!!”
Title: CCL5 derived from platelets increases megakaryocyte proplatelet formation
Authors: Kellie R. Machlus, Kelly E. Johnson, Rajesh Kulenthirarajan, Jodi A. Forward, Mason D. Tippy, Thomas S. Soussou, Saleh H. El-Husayni, Stephen K. Wu, Suming Wang, Randolph S. Watnick, Joseph E. Italiano Jr., Elisabeth M. Battinelli
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe LippiÖ‰ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question